Alzheimer's disease: Effects of β-amyloid on mitochondria

Mitochondrion

Volumn 11, Issue 1, 2011, Pages 13-21

  Tillement, Laurent ^a,b   Lecanu, Laurent ^a,b,c   Papadopoulos, Vassilios ^a,b,c  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

amyloid; Alzheimer's disease; Mitochondria; Mitochondrial dysfunction; Neurodegenerative diseases

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CYTOCHROME C OXIDASE; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MITOCHONDRIAL DNA; MITOCHONDRIAL RNA; NITRIC OXIDE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REACTIVE OXYGEN METABOLITE; TAU PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; CALCIUM HOMEOSTASIS; CELL MEMBRANE; CELL ORGANELLE; CHROMATIN CONDENSATION; CYTOKINE PRODUCTION; DETOXIFICATION; DISEASE TRANSMISSION; DNA FRAGMENTATION; DNA REPLICATION; HUMAN; INTERNALIZATION; LIPID PEROXIDATION; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; MOLECULAR DYNAMICS; NERVE CELL DEGENERATION; NEUROFIBRILLARY TANGLE; OXIDATIVE STRESS; PATHOGENESIS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REVIEW; RNA SYNTHESIS;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; CELL LINE; HUMANS; MITOCHONDRIA; RATS;

EID: 78649983748     PISSN: 15677249     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mito.2010.08.009     Document Type: Review

References (81)

1. Alexeyev M.F., Ledoux S.P., Wilson G.L. Mitochondrial DNA and aging. Clin. Sci. 2004, 107:355-364.
2. Arispe N., Rojas E., Pollard H.B. Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. Proc. Natl Acad. Sci. USA 1993, 90:567-571.
3. Bannwarth S., Procaccio V., Paquis-Flucklinger V. Rapid identification of unknown heteroplasmic mutations across the entire human mitochondrial genome with mismatch-specific Surveyor Nuclease. Nat. Protoc. 2006, 1:2037-2047.
4. Brown G.C., Borutaite V. Nitric oxide inhibition of mitochondrial respiration and its role in cell death. Free Radic. Biol. Med. 2002, 33:1440-1450.
5. Burns A., Iliffe S. Alzheimer's disease. BMJ 2009, 338:b158.
6. Carney J.M., Starke-Reed P.E., Oliver C.N., Landum R.W., Cheng M.S., Wu J.F., Floyd R.A. Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-alpha- phenylnitrone. Proc. Natl Acad. Sci. USA 1991, 88:3633-3636.
7. Cataldo A.M., Hamilton D.J., Nixon R.A. Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease. Brain Res. 1994, 640:68-80.
8. Chan D.C. Mitochondrial fusion and fission in mammals. Annu. Rev. Cell Dev. Biol. 2006, 22:79-99.
9. Cho D.H., Nakamura T., Fang J., Cieplak P., Godzik A., Gu Z., Lipton S.A. S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury. Science 2009, 324:102-105.
10. Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem. J. 1999, 341:233-249.
11. Csordás G., Thomas A.P., Hajnóczky G. Quasi-synaptic calcium signal transmission between endoplasmic reticulum and mitochondria. EMBO 1999, 18:96-108.
12. Davis C.H., Berkowitz M.L. Structure of the amyloid-β (1-42) monomer absorbed to model phospholipid bilayers: a molecular dynamics study. J. Phys. Chem. B 2009, 113:14480-14486.
13. Davis R.E., Miller S., Herrnstadt C., Ghosh S.S., Fahy E., Shinobu L.A., Galasko D., Thal L.J., Beal M.F., Howell N., Parker W.D. Mutations in mitochondrial cytosome c oxidase genes segregate with late-onset Alzheimer disease. Proc. Natl Acad. Sci. 1997, 94:4526-4531. Retraction: Proc. Nat. Acad. Sci.: 95 (1998), pp. 12069 only.
14. Du H., Guo L., Fang F., Chen D., Sosunov A.A., McKhann G.M., Yan Y., Wang C., Zhang H., Molkentin J.D., Gunn-Moore F.J., Vonsattel J.P., Arancio O., Chen J.X., Yan S.D. Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease. Nat. Med. 2008, 14:1097-1105.
15. Engel M.F. Membrane permeabilization by islet amyloid polypeptide. Chem. Phys. Lipids 2009, 160:1-10.
16. Estus S., Tucker H.M., van Rooyen C., Wright S., Brigham E.F., Wogulis M., Rydel R.E. Aggregated amyloid-beta protein induces cortical neuronal apoptosis and concomitant "apoptotic" pattern of gene induction. J. Neurosci. 1997, 17:7736-7745.
17. Ferreiro E., Oliveira C.R., Pereira C.M. The release of calcium from the endoplasmic reticulum induced by amyloid-beta and prion peptides activates the mitochondrial apoptotic pathway. Neurobiol. Dis. 2008, 30:331-342.
18. Goldsbury C., Whiteman I.T., Jeong E.V., Lim Y.A. Oxidative stress increases levels of endogenous amyloid-beta peptides secreted from primary chick brain neurons. Aging Cell 2008, 7:771-775.
19. Gouras G.K., Tsai J., Naslund J., Vincent B., Edgar M., Checler F., Greenfield J.P., Haroutunian V., Buxbaum J.D., Xu H., Greengard P., Relkin N.R. Intraneuronal Aß42 Accumulation in human brain. Am. J. Pathol. 2000, 156:15-20.
20. Grünblatt E., Zehetmayer S., Bartl J., Löffler C., Wichart I., Rainer M.K., Jungwirth S., Bauer P., Danielczyk W., Tragl K.H., Riederer P., Fischer P. Genetic risk factors and markers for Alzheimer's disease and/or depression in the VITA study. J. Psychiatr. Res. 2009, 43:298-308.
21. Guo L., Salt T.E., Luong V., Wood N., Cheung W., Maass A., Ferrari G., Russo-Marie F., Sillito A.M., Cheetham M.E., Moss S.E., Fitzke F.W., Cordeiro M.F. Targeting amyloid-beta in glaucoma treatment. Proc. Natl Acad. Sci. USA 2007, 104:13444-13449.
22. Hansson Petersen C.A., Alikhani N., Behbahani H., Wiehager B., Pavlov P.F., Alafuzoff I., Leinonen V., Ito A., Winblad B., Glaser E., Ankarcrona M. The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae. Proc. Natl. Acad. Sci. USA 2008, 105:13145-13150.
23. Hauptmann S., Scherping I., Dröse S., Brandt U., Schulz K.L., Jendrach M., Leuner K., Eckert A., Müller W.E. Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice. Neurobiol. Aging 2009, 30:1574-1586.
24. Hsu M.J., Sheu J.R., Lin C.H., Shen M.Y., Hsu C.Y. Mitochondrial mechanisms in amyloid beta peptide-induced cerebrovascular degeneration. Biochim. Biophys. Acta 2009, 1800:290-296.
25. Hureau C., Faller P. Aβ-mediated ROS production by Cu ions: structural insights, mechanisms and relevance to Alzheimer's disease. Biochimie 2009, 91:1212-1217.
26. Jaksch M., Gerbitz K.D., Kilger C. Screening for mitochondrial DNA (mtDNA) point mutations using nonradioactive single strand conformation polymorphism (SSCP) analysis. Clin. Biochem. 1995, 28:503-509.
27. Janson J., Ashley R.H., Harrison D., McIntyre S., Butler P.C. The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes 1999, 48:491-498.
28. Jungbauer L.M., Yu C., Laxton K.J., LaDu M.J. Preparation of fluorescently-labeled amyloid-beta peptide assemblies: the effect of fluorophore conjugation on structure and function. J. Mol. Recognit. 2009, 22(5):403-413.
29. Kagan B.L., Azimov R.H., Azimova R. Amyloid peptide channels. J. Membr. Biol. 2004, 202:1-10.
30. Kandimalla K.K., Scott O.G., Fulzele S., Davidson M.W., Poduslo J.F. Mechanism of neuronal versus endothelial cell uptake of Alzheimer's disease amyloid beta protein. PLoS ONE 2009, 4:e4627.
31. Keil U., Bonert A., Marques C.A., Scherping I., Weyermann J., Strosznajder J.B., Müller-Spahn F., Haass C., Czech C., Pradier L., Müller W.E., Eckert A. Amyloid beta-induced changes in nitric oxide production and mitochondrial activity lead to apoptosis. J. Biol. Chem. 2004, 279:50310-50320.
32. Kim H.S., Lee J.H., Lee J.P., Kim E.M., Chang K.A., Park C.H., Jeong S.J., Wittendorp M.C., Seo J.H., Choi S.H., Suh Y.H. Amyloid beta peptide induces cytochrome C release from isolated mitochondria. NeuroReport 2002, 13:1989-1993.
33. Klein W.L. Aβ toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets. Neurochem. Int. 2002, 41:345-352.
34. Kulic, L., Wollmer, M.A., Rhein, V., Pagani, L., Kuehnle, K., Cattepoel, S., Tracy, J., Eckert, A., Nitsch, R.M., in press. Combined expression of tau and the Harlequin mouse mutation leads to increased mitochondrial dysfunction, tau pathology and neurodegeneration. Neurobiol. Aging PMID: 19942317.
35. Lal R., Lin H., Quist A.P. Amyloid beta ion channel: 3D structure and relevance to amyloid channel paradigm. Biochim. Biophys. Acta 2007, 1768:1966-1975.
36. Lapointe J., Hekimi S. When a theory of aging ages badly. Cell. Mol. Life Sci. 2009, 67:1-8.
37. Lecanu L., Tillement L., Rammouz G., Tillement J.P., Greeson J., Papadopoulos V. Caprospinol: moving from a neuroactive steroid to a neurotropic drug. Expert Opin. Investig. Drugs 2009, 18:265-276.
38. Lee H.R., Johnson K.A. Fidelity of the human mitochondrial DNA polymerase. J. Biol. Chem. 2006, 281:36236-36240.
39. Li Y.P., Bushnell A.F., Lee C.M., Perlmutter L.S., Wong S.K. Beta-amyloid induces apoptosis in human-derived neurotypic SH-SY5Y cells. Brain Res. 1996, 738:196-204. Nov 4.
40. Loo D.T., Copani A., Pike C.J., Whittemore E.R., Walencewicz A.J., Cotman C.W. Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc. Natl Acad. Sci. USA 1993, 90:7951-7955.
41. Lustbader J.W., Cirilli M., Lin C., Xu H.W., Takuma K., Wang N., Caspersen C., Chen X., Pollak S., Chaney M., Trinchese F., Liu S., Gunn-Moore F., Lue L.F., Walker D.G., Kuppusamy P., Zewier Z.L., Arancio O., Stern D., Yan S.S., Wu H. ABAD directly links Aß to mitochondrial toxicity in Alzheimer's Disease. Science 2004, 304:448-452.
42. Marín N., Romero B., Bosch-Morell F., Llansola M., Felipo V., Romá J., Romero F.J. Beta-amyloid-induced activation of caspase-3 in primary cultures of rat neurons. Mech. Ageing Dev. 2000, 119:63-67.
43. McAlpine F.E., Lee J.K., Harms A.S., Ruhn K.A., Blurton-Jones M., Hong J., Das P., Golde T.E., LaFerla F.M., Oddo S., Blesch A., Tansey M.G. Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology. Neurobiol. Dis. 2009, 34:163-177.
44. Minogue A.M., Schmid A.W., Fogarty M.R., Moore A.C., Campbell V.A., Herron C.E., Lynch M.A. Activation of the c-Jun N-terminal kinase signaling cascade mediates the effect of amyloid-β on long term potentiation and cell death in hippocampus. A role for interleukin-1 β. J. Biol. Chem. 2003, 278:27971-27980.
45. Mironov S.L., Ivannikov M.V., Johansson M. Ca2+]i signaling between mitochondria and endoplasmic reticulum in neurons is regulated by microtubules. From mitochondrial permeability transition pore to Ca2+-induced Ca2+ release. J. Biol. Chem. 2005, 280:715-721.
46. Misumi Y., Ando Y., Ueda M., Obayashi K., Jono H., Su Y., Yamashita T., Uchino M. Chain reaction of amyloid fibril formation with induction of basement membrane in familial amyloidotic polyneuropathy. J. Pathol. 2009, 219:481-490.
47. Moreira P.I., Santos M.S., Moreno A., Rego A.C., Oliveira C. Effect of amyloid beta-peptide on permeability transition pore: a comparative study. J. Neurosci. Res. 2002, 69:257-267.
48. Morishima Y., Gotoh Y., Zieg J., Barrett T., Takano H., Flavell R., Davis R.J., Shirasaki Y., Greenberg M.E. Beta-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand. J. Neurosci. 2001, 21:7551-7560.
49. Murakami Y., Ohsawa I., Kasahara T., Ohta S. Cytoprotective role of mitochondrial amyloid beta peptide-binding alcohol dehydrogenase against a cytotoxic aldehyde. Neurobiol. Aging 2009, 30:325-329.
50. Nunomura A., Hofer T., Moreira P.I., Castellani R.J., Smith M.A., Perry G. RNA oxidation in Alzheimer disease and related neurodegenerative disorders. Acta Neuropathol. 2009, 118:151-166.
51. Ohyagi Y., Asahara H., Chui D.H., Tsuruta Y., Sakae N., Miyoshi K. Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease. FASEB J. 2005, 19:255-257.
52. Parfait B., Chretien D., Rötig A., Marsac C., Munnich A., Rustin P. Compound heterozygous mutations in the flavoprotein gene of the respiratory chain complex II in a patient with Leigh syndrome. Hum. Genet. 2000, 106:236-243.
53. Powell A.J., Read J.A., Banfield M.J., Gunn-Moore F., Yan S.D., Lustbader J., Stern A.R., Stern D.M., Brady R.L. Recognition of structurally diverse substrates by type II 3-hydroxyacyl-CoA dehydrogenase (HADH II)/Amyloid-β binding alcohol dehydrogenase (ABAD). J. Mol. Biol. 2000, 303:311-327.
54. Reddy P.H. Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease. Exp. Neurol. 2009, 218:286-292.
55. Reddy V.P., Zhu X., Perry G., Smith M.A. Oxidative stress in diabetes and Alzheimer's disease. J. Alzheimers Dis. 2009, 16:763-774.
56. Rhein V., Baysang G., Rao S., Meier F., Bonert A., Müller-Spahn F., Eckert A. Amyloid-beta leads to impaired cellular respiration, energy production and mitochondrial electron chain complex activities in human neuroblastoma cells. Cell. Mol. Neurobiol. 2009, 29:1063-1071.
57. Rui Y., Tiwari P., Xie Z., Zheng J.Q. Acute impairment of mitochondrial trafficking by beta-amyloid peptides in hippocampal neurons. J. Neurosci. 2006, 26:10480-10487.
58. Salminen A., Ojala J., Suuronen T., Kaarniranta K., Kauppinen A. Amyloid-beta oligomers set fire to inflammasomes and induce Alzheimer's pathology. J. Cell. Mol. Med. 2008, 12:2255-2262.
59. Salminen A., Ojala J., Kauppinen A., Kaarniranta K., Suuronen T. Inflammation in Alzheimer's disease: amyloid-beta oligomers trigger innate immunity defense via pattern recognition receptors. Prog. Neurobiol. 2009, 87:181-194.
60. Schipper H.M. Apolipoprotein E: implications for AD neurobiology, epidemiology and risk assessment. Neurobiol. Aging 2009, PMID: 19482376.
61. Schmidt C., Lepsverdize E., Chi S.L., Das A.M., Pizzo S.V., Dityatev A., Schachner M. Amyloid precursor protein and amyloid beta-peptide bind to ATP synthase and regulate its activity at the surface of neural cells. Mol. Psychiatry 2008, 13:953-969.
62. Sergeant N., Wattez A., Galvan-Valencia M., Ghestem A., David J.P., Lemoine J. Association of ATP synthase alpha-chain with neurofibrillary degeneration in Alzheimer's disease. Neuroscience 2003, 117:293-303.
63. Shastry B.S., Giblin F.J. Genes and susceptible loci of Alzheimer's disease. Brain Res. Bull. 1999, 48:121-127.
64. Sheng B., Gong K., Niu Y., Liu L., Yan Y., Lu G., Zhang L., Hu M., Zhao N., Zhang X., Tang P., Gong Y. Inhibition of β-secretase activity reduces Aβ production, reduces oxidative stress, increases mitochondrial activity and leads to reduced vulnerability to apoptosis: Implications for the treatment of Alzheimer's disease. Free Radic. Biol. Med. 2009, 46:1362-1375.
65. Shibata M., Yamada S., Kumar S.R., Calero M., Bading J., Frangione B., Holtzman D.M., Miller C.A., Strickland D.K., Ghiso J., Zlokovic B.V. Clearance of Alzheimer's amyloid β(1-40)-peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J. Clin. Invest. 2000, 106:1489-1499.
66. Singh S., Suman S., Chandna S., Das T.K. Possible role of amyloid-beta, adenine nucleotide translocase and cyclophilin-D interaction in mitochondrial dysfunction of Alzheimer's disease. Bioinformation 2009, 3:440-445.
67. Tarkowski E., Andreasen N., Tarkowski A., Blennow K. Intrathecal inflammation precedes development of Alzheimer's disease. Neurol. Neurosurg. Psychiatry 2003, 74:1200-1205.
68. Thal D.R., Rüb U., Orantes M., Braak H. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 2002, 58:1791-1800.
69. Tillement L., Lecanu L., Yao W., Greeson J., Papadopoulos V. The spirostenol (22R, 25R)-20alpha-spirost-5-en-3beta-yl hexanoate blocks mitochondrial uptake of Abeta in neuronal cells and prevents Abeta-induced impairment of mitochondrial function. Steroids 2006, 71:725-735.
70. Turrens J.F. Mitochondrial formation of reactive oxygen species. J. Physiol. 2003, 552:335-344.
71. Volicer L., Crino P.B. Involvement of free radicals in dementia of the Alzheimer type: a hypothesis. Neurobiol. Aging 1990, 11:567-571.
72. Wakayama T., Shinkai Y., Tamashiro K.L., Niida H., Blanchard D.C., Blanchard R.J., Ogura A., Tanemura K., Tachibana M., Perry A.C. Ageing: cloning of mice to six generations. Nature 2000, 407:318-319.
73. Wallace D.C., Lott M.T. MITOMAP: a human mitochondrial genome database 2006, http://www.mitomap.org.
74. Wang X., Su B., Siedlak S.L., Moreira P.I., Fujioka H., Wang Y., Casadesus G., Zhu X. Amyloid-β overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc. Natl Acad. Sci. USA 2008, 105:19318-19323.
75. Wang X., Su B., Lee H.G., Li X., Perry G., Smith M.A., Zhu X. Impaired balance of mitochondrial fission and fusion in Alzheimer's disease. J. Neurosci. 2009, 29:9090-9103.
76. Wang X., Perry G., Smith M.A., Zhu X. Amyloid-beta-derived diffusible ligands cause impaired axonal transport of mitochondria in neurons. Neurodegener. Dis. 2010, 7:56-59.
77. Yin K.J., Lee J.M., Chen H., Xu J., Hsu C.Y. Abeta25-35 alters Akt activity, resulting in Bad translocation and mitochondrial dysfunction in cerebrovascular endothelial cells. J. Cereb. Blood Flow Metab. 2005, 25:1445-1455.
78. Yu C., Nwabuisi-Heath E., Laxton K., Ladu M.J. Endocytic pathways mediating oligomeric Abeta42 neurotoxicity. Mol. Neurodegener. 2010, 17:5-19.
79. Zhang Y., Tian Q., Zhang Q., Zhou X., Liu S., Wang J.Z. Hyperphosphorylation of microtubule-associated tau protein plays dual role in neurodegeneration and neuroprotection. Pathophysiology 2009, 16:311-316.
80. Zhao X.L., Wang W.A., Tan J.X., Huang J.K., Zhang X., Zhang B.Z., Wang Y.H., YangCheng H.Y., Zhu H.L., Sun X.J., Huang FD F.D. Expression of beta-amyloid induced age-dependent presynaptic and axonal changes in Drosophila. J. Neurosci. 2010, 30:1512-1522.
81. Zheng H., Koo E.H. The amyloid precursor protein: beyond amyloid. Mol. Neurodegener. 2006, 1:5.